Nonsteroidal antiandrogen

This page covers all Nonsteroidal antiandrogen drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Androgen receptor, androgen receptor.

Targets

Androgen receptor · androgen receptor

Phase 3 pipeline (2)

• Standard Darolutamide · Jena University Hospital · Oncology
  Darolutamide is a nonsteroidal antiandrogen that competitively inhibits the action of androgens, such as testosterone and dihydrotestosterone, at their receptor sites in various tissues.
• Placebo of Darolutamide · Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie · Oncology
  Darolutamide is a nonsteroidal antiandrogen that competitively inhibits the action of androgens, such as testosterone and dihydrotestosterone, at their receptor sites in various tissues.

Phase 2 pipeline (1)

• Bicalutamide Oral Product · Gynaecologisch Oncologisch Centrum Zuid · Oncology
  Bicalutamide is a nonsteroidal antiandrogen that inhibits the action of androgens.